出来高 | 24,520 |
|
|||||
ニュース | (1) | ||||||
今日の高値 | 1.43 | 安値 高値 |
|||||
今日の安値 | 1.35 |
企業情報 - AEON Biopharma Inc
時価総額 | 発行済株式数 | Float | 歳入 | 利益/損失 | 一株当たり利益 | PER |
---|---|---|---|---|---|---|
50.91M | 37.16M | - | 52.75M | 24.05M | 0.65 | 2.12 |
Short Interest | 1株あたり配当 | 配当利回り | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
ニュース - AEON Biopharma
日付 | 時間 | 情報元 | タイトル |
---|---|---|---|
2024/6/15 | 05:06 | Edgar (US Regulatory) | Form 8-K - Current report |
2024/6/01 | 05:03 | Edgar (US Regulatory) | Form S-1/A - General form for registration of securities.. |
2024/5/25 | 09:02 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of.. |
2024/5/17 | 05:27 | Edgar (US Regulatory) | Form 8-K - Current report |
2024/5/15 | 05:07 | Edgar (US Regulatory) | Form 8-K - Current report |
2024/5/14 | 22:15 | Edgar (US Regulatory) | Form ARS/A - Annual Report to Security Holders: [Amend] |
2024/5/14 | 22:14 | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting.. |
2024/5/14 | 22:05 | Edgar (US Regulatory) | Form 10-K/A - Annual report [Section 13 and 15(d), not S-K.. |
2023/11/23 | 11:48 | Edgar (US Regulatory) | Form S-1/A - General form for registration of securities.. |
2023/11/13 | 23:01 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
2023/11/13 | 23:00 | Edgar (US Regulatory) | Form 8-K - Current report |
2023/10/20 | 05:23 | Edgar (US Regulatory) | Form 8-K - Current report |
チャート - AEON Biopharma
期間 † | 始値 | 高値 | 安値 | VWAP | 平均出来高 | 前日比 | % |
---|---|---|---|---|---|---|---|
1週 | 1.59 | 1.80 | 1.35 | 1.51 | 37,732 | -0.10 | -6.29% |
1ヶ月 | 1.50 | 2.08 | 1.26 | 1.58 | 83,775 | -0.01 | -0.67% |
3ヶ月 | 10.83 | 12.93 | 1.26 | 3.48 | 92,382 | -9.34 | -86.24% |
6ヶ月 | 5.62 | 17.17 | 1.26 | 6.43 | 64,961 | -4.13 | -73.49% |
1年 | 10.14 | 17.17 | 1.26 | 6.32 | 69,500 | -8.65 | -85.31% |
3年 | 10.14 | 17.17 | 1.26 | 6.32 | 69,500 | -8.65 | -85.31% |
5年 | 10.14 | 17.17 | 1.26 | 6.32 | 69,500 | -8.65 | -85.31% |